CBUS · Cibus, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.68M | - | $615.0K | $933.0K | $1.03M | - | $1.67M | $838.0K | $545.0K | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $8.72M | - | $10.78M | $12.23M | $11.80M | - | $12.99M | $12.99M | $12.01M | - |
| SG&A | $5.08M | - | $5.27M | $6.65M | $9.86M | - | $7.68M | $9.33M | $6.99M | - |
| Total Operating Expenses | $13.80M | - | $16.05M | $18.88M | $42.60M | - | $202.10M | $22.32M | $19.00M | - |
| D&A | $1.20M | - | $939.0K | $1.09M | $1.63M | - | $1.17M | $1.27M | $1.79M | - |
| Operating Income | ($12.12M) | - | ($15.44M) | ($17.95M) | ($41.57M) | - | ($200.44M) | ($21.48M) | ($18.45M) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $7.0K | - | ($6.0K) | $27.0K | $2.0K | - | $13.0K | ($4.0K) | $14.0K | - |
| Net Income | ($21.22M) | - | ($23.54M) | ($25.37M) | ($46.89M) | - | ($179.97M) | ($24.88M) | ($23.43M) | - |
| EPS - Basic | ($0.33) | - | ($0.44) | ($0.61) | ($1.34) | - | ($7.63) | ($1.14) | ($1.12) | - |
| EPS - Diluted | ($0.33) | - | ($0.44) | ($0.61) | ($1.34) | - | ($7.63) | ($1.14) | ($1.12) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30.32M | $9.92M | $23.89M | $36.46M | $23.59M | $14.43M | $28.80M | $30.02M | $24.51M | $32.70M |
| Accounts Receivable | $1.70M | $503.0K | $604.0K | $953.0K | $950.0K | $1.04M | $1.19M | $1.06M | $500.0K | $530.0K |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $5.41M | $8.07M | $5.98M | $5.93M | $6.78M | $5.96M | $7.02M | $6.20M | $6.67M | $6.13M |
| Current Assets | $33.07M | $12.07M | $26.24M | $39.84M | $25.88M | $16.95M | $31.57M | $33.10M | $26.72M | $35.22M |
| Total Assets | $324.20M | $305.05M | $330.23M | $346.20M | $335.05M | $350.07M | $367.87M | $553.38M | $533.03M | $544.41M |
| Current Liabilities | $13.94M | $16.86M | $20.56M | $22.42M | $21.01M | $19.88M | $21.92M | $28.97M | $21.72M | $21.32M |
| Long-term Debt | $73.0K | $93.0K | $116.0K | $140.0K | $180.0K | $226.0K | $291.0K | $365.0K | $441.0K | $536.0K |
| Total Liabilities | $288.72M | $283.22M | $278.20M | $271.72M | $261.09M | $252.24M | $246.99M | $246.31M | $213.21M | $206.12M |
| Stockholders' Equity | $35.48M | $21.83M | $50.40M | $72.12M | $70.27M | $92.16M | $108.14M | $270.50M | $278.22M | $293.47M |
| Retained Earnings | ($879.47M) | ($858.25M) | ($826.97M) | ($803.42M) | ($778.05M) | ($731.17M) | ($708.06M) | ($528.10M) | ($503.21M) | ($479.78M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($11.49M) | - | - | - | ($11.83M) | - | - | - | ($13.48M) | - |
| Investing Cash Flow | ($72.0K) | - | - | - | ($291.0K) | - | - | - | ($228.0K) | - |
| Financing Cash Flow | $31.96M | - | - | - | $21.27M | - | - | - | $5.52M | - |
| CapEx | $115.0K | - | - | - | $291.0K | - | - | - | $228.0K | - |
| Free Cash Flow | ($11.60M) | - | - | - | ($12.12M) | - | - | - | ($13.71M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -721.0% | - | -2510.2% | -1923.5% | -4020.4% | - | -12023.8% | -2563.5% | -3385.9% | - |
| EBITDA margin | -649.8% | - | -2357.6% | -1806.3% | -3862.4% | - | -11953.5% | -2411.5% | -3056.7% | - |
| Net margin | -1262.5% | - | -3827.8% | -2719.4% | -4534.4% | - | -10795.9% | -2969.3% | -4300.0% | - |
| Free cash flow margin | -690.1% | - | - | - | -1172.0% | - | - | - | -2515.2% | - |
| FCF / Net income | 0.55 | - | - | - | 0.26 | - | - | - | 0.58 | - |
| R&D / Revenue | 518.6% | - | 1753.5% | 1310.6% | 1141.1% | - | 779.2% | 1550.5% | 2204.2% | - |
| SG&A / Revenue | 302.4% | - | 856.7% | 712.9% | 953.2% | - | 460.8% | 1113.0% | 1281.7% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -6.5% | - | -7.1% | -7.3% | -14.0% | - | -48.9% | -4.5% | -4.4% | - |
| Return on equity | -59.8% | - | -46.7% | -35.2% | -66.7% | - | -166.4% | -9.2% | -8.4% | - |
| Return on invested capital | -26.9% | - | -24.1% | -19.6% | -46.6% | - | -146.0% | -6.3% | -5.2% | - |
| Liquidity | ||||||||||
| Current ratio | 2.37 | 0.72 | 1.28 | 1.78 | 1.23 | 0.85 | 1.44 | 1.14 | 1.23 | 1.65 |
| Quick ratio | 2.37 | 0.72 | 1.28 | 1.78 | 1.23 | 0.85 | 1.44 | 1.14 | 1.23 | 1.65 |
| Cash ratio | 2.17 | 0.59 | 1.16 | 1.63 | 1.12 | 0.73 | 1.31 | 1.04 | 1.13 | 1.53 |
| Leverage | ||||||||||
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt / Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 9.14 | 13.97 | 6.55 | 4.80 | 4.77 | 3.80 | 3.40 | 2.05 | 1.92 | 1.86 |
| Liabilities / Assets | 0.89 | 0.93 | 0.84 | 0.78 | 0.78 | 0.72 | 0.67 | 0.45 | 0.40 | 0.38 |
| Efficiency | ||||||||||
| Asset turnover | 0.01 | - | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 370d | - | 358d | 373d | 335d | - | 261d | 461d | 335d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | 3.6x | - | 1.4x | 0.8x | 0.9x | - | 0.7x | 0.8x | - | - |
| P / S | 76.8x | - | 111.0x | 61.6x | 63.4x | - | 46.1x | 256.9x | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 62.6% | - | -63.1% | 11.3% | 89.7% | - | 250.9% | 325.4% | 1197.6% | - |
| Revenue CAGR (3y) | 242.1% | - | 144.6% | 183.4% | 218.5% | - | -40.1% | -58.7% | -50.2% | - |
| Revenue CAGR (5y) | -17.5% | - | -34.9% | -16.6% | -15.3% | - | -10.9% | 15.5% | 28.3% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 70.8% | - | 92.3% | 16.5% | -125.3% | - | -677.0% | -11.2% | -313.5% | - |
| Net income growth (YoY) | 54.7% | - | 86.9% | -2.0% | -100.1% | - | -580.9% | -33.1% | -334.5% | - |
| EPS growth (YoY) | 75.4% | - | 94.2% | 46.5% | -19.6% | - | -379.9% | 62.6% | -2.8% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 4.3% | - | - | - | 11.6% | - | - | - | -477.2% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -49.5% | -76.3% | -53.4% | -73.3% | -74.7% | -68.6% | -76.7% | -44.1% | 10331.8% | 3957.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$3.64M totalReportable Segment$3.64M · 100.0%
Peer comparison
Same SIC group: Agricultural Chemicals
Comparing Cibus against the 5 most active filers in the same SIC group.